Literature DB >> 21854688

Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICE.

Rachel Baker1, Sue Chilton, Cam Donaldson, Michael Jones-Lee, Emily Lancsar, Helen Mason, Hugh Metcalf, Mark Pennington, John Wildman.   

Abstract

Recently, for many health economics researchers, empirical estimation of the monetary valuation of a quality-adjusted life year (QALY) has become an important endeavour. Different philosophical and practical approaches to this have emerged. On the one hand, there is a view that, with health-care budgets set centrally, decision-making bodies within the system can iterate, from observation of a series of previous decisions, towards the value of a QALY, thus searching for such a value. Alternatively, and more consistent with the approach taken in other public sectors, individual members of the public are surveyed with the aim of directly eliciting a preference-based - also known as a willingness-to-pay-based (WTP-based) - value of a QALY. While the former is based on supply-side factors and the latter on demand, both in fact suffer from informational deficiencies. Sole reliance on either would necessitate an acceptance or accommodation of chronic inefficiencies in health-care resource allocation. On the basis of this observation, this paper makes the case that in order to approach optimal decision making in health-care provision, a framework incorporating and thus, to a degree, reconciling these two approaches is to be preferred.

Entities:  

Mesh:

Year:  2011        PMID: 21854688     DOI: 10.1017/S1744133111000181

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  12 in total

1.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

2.  Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness.

Authors:  Mikael Svensson; Fredrik O L Nilsson; Karl Arnberg
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

3.  Value of a QALY and VSI estimated with the chained approach.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2019-06-06

4.  Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2017-08-12

5.  The societal monetary value of a QALY associated with EQ-5D-3L health gains.

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Oliver Rivero-Arias; José Luis Pinto-Prades
Journal:  Eur J Health Econ       Date:  2019-11-28

6.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

Review 7.  A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?

Authors:  Khachapon Nimdet; Nathorn Chaiyakunapruk; Kittaya Vichansavakul; Surachat Ngorsuraches
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

8.  Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.

Authors:  Jesus Martín-Fernández; Elena Polentinos-Castro; Ma Isabel del Cura-González; Gloria Ariza-Cardiel; Victor Abraira; Ana Isabel Gil-LaCruz; Sonia García-Pérez
Journal:  BMC Health Serv Res       Date:  2014-07-03       Impact factor: 2.655

Review 9.  On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.

Authors:  David Cameron; Jasper Ubels; Fredrik Norström
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

10.  Cost-Effectiveness Threshold for Healthcare: Justification and Quantification.

Authors:  Moshe Yanovskiy; Ori N Levy; Yair Y Shaki; Avi Zigdon; Yehoshua Socol
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.